Compugen医疗 CGEN 深 沪
已收盘 10-23 16:00:00 美东时间
1.94
-0.020
-1.02%
华盛通- 最 高1.97
- 今 开1.97
- 成交量 14.80万股
- 最 低 1.89
- 昨 收 1.96
- 总市值 1.84亿
- 52周最高 3.235
- 市盈率 静 5.15
- 换手率 0.16%
- 52周最低 1.43
- 委 比 30.04%
- 总股本 9472.79万
- 历史最高 19.90
- 量 比 0.43
- 振 幅 4.08%
- 历史最低 0.51
- 每 手 1
- 风险率 0.41%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Compugen医疗收涨0.51%，成交额31.44万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-20 06:46
Compugen医疗收跌5.77%，成交额33.7万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 06:46
美股大行评级 | 潜在涨幅386.16%！摩根士丹利维持TeraWulf"超配"评级，上调目标价至65美元
今日重点评级关注：摩根士丹利：维持TeraWulf"超配"评级，目标价从62.5美元升至65美元；摩根士丹利：维持Hut 8"超配"评级，目标价从273美元升至275美元
10-13 12:30
HC Wainwright & Co. Reiterates Buy on Compugen, Maintains $4 Price Target
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Compugen (NASDAQ:CGEN) with a Buy and maintains $4 price target.
10-12 19:30
Compugen Q2 EPS $(0.07), Inline, Sales $2.602M Beat $1.606M Estimate
Compugen (NASDAQ:CGEN) reported quarterly losses of $(0.07) per share which met the analyst consensus estimate. This is a 12.5 percent increase over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $2.602 million which beat the analyst consensus est...
08-03 19:01
Compugen Reports Second Quarter 2026 Results
COM701 MAIA-ovarian trial progressing as planned with median progression-free survival data from the interim analysis expected by Q1 2027 Trial-in-progress poster on MAIA-ovarian presented a...
08-03 19:00
Compugen To Present Trial-In-Progress Poster On MAIA-Ovarian Phase 1 Study Of COM701, Anti-PVRIG Antibody, At ESMO Gynaecological Cancers Congress 2026
Compugen Ltd. (NASDAQ:CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational drug target discovery powered by AI/ML, today announced that it will present a trial-in-progress poster on the MAIA-ovarian Phase 1 study of COM701, a potential first-in-c...
06-11 19:14
Compugen Q1 2026 Earnings Call: Complete Transcript
On Monday, Compugen (NASDAQ:CGEN) discussed first-quarter financial results dur...
06-01 21:04
美股大行评级 | 英伟达绩后获11家大行集体上调目标价；劳氏、ELF、Intuit、VF等惨遭多家大行下调目标价
今日重点评级关注：康托·菲茨杰拉德：维持Ultragenyx药业"超配"评级，目标价从84美元升至96美元；Ascendiant Capital：维持Liqtech国际"买入"评级，目标价从4.3美元升至4.4美元
05-22 10:18
Leerink Partners Maintains Outperform on Compugen, Lowers Price Target to $5
Leerink Partners maintains Compugen (NASDAQ:CGEN) with a Outperform and lowers the price target from $13 to $5.
05-21 22:38
